Dr. Albert Bourla is also troubled by this trend ... first for emergency use in December 2020 and then for full approval in August 2021. It’s also the vaccine that Israel has given to ...

Pfizer CEO Albert Bourla said there are "opportunities that probably outweigh the risks" of the Trump administration's ...

Albert Bourla, CEO of Pfizer since 2019 ... That move alone nearly doubled Pfizer’s revenues in fiscal year 2021 to around $81.3 billion. Since then, the company has fallen behind in the ...

Few CEOs know the double-edged nature of dealing with US President Donald Trump as viscerally as Pfizer’s Albert Bourla ... Joe Biden called Bourla “a good friend” in 2021, but Pfizer ...

Pfizer has promoted Albert Bourla, seen as a likely successor to incumbent CEO Ian Read, to the newly-created role of chief operating officer. The move could help Read focus on long-term strategy ...

In an interview on CNBC’s Mad Money, Dr. Albert Bourla said Pfizer (PFE) is focusing on business development to create shareholder value. “We ...

CEO Albert Bourla says Pfizer has met the strategic goals it had set for itself in 2024, and that it was ‘executing transformative changes.’ ...

SAN FRANCISCO — At the end of a roundtable lunch with a group of reporters, Pfizer CEO Albert Bourla became impassioned. He admitted that after the company made a “big miscalculation” around ...

Pfizer’s CEO Ian Read is to step down after eight years and will be replaced on 1st January by chief operating officer Albert Bourla. In contrast to Merck & Co. which has rescinded a company ...

(Bloomberg) -- Pfizer Inc. and Albert Bourla got the upper hand in an early ... the drugmaker have fallen by more than 50% ...

Pfizer is cutting costs and refocussing its research and development (R&D) operations in a bid to maintain and grow revenues in 2025, says CEO Albert Bourla. The company achieved its 2024 goal of ...